Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Robert H. Lurie Cancer Center National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00739167 |
RATIONALE: Learning about quality of life in patients with cancer undergoing embolization may help doctors learn about the side effects of treatment and plan the best treatment.
PURPOSE: This clinical trial is studying quality of life in patients undergoing embolization using yttrium Y 90 glass microspheres for primary or metastatic liver cancer.
Condition | Intervention |
---|---|
Liver Cancer Metastatic Cancer |
Other: survey administration Procedure: quality-of-life assessment Radiation: yttrium Y 90 glass microspheres |
Study Type: | Observational |
Official Title: | A Quality of Life Study for Patients With Primary or Metastatic Liver Cancer Who Are Treated With Radioembolization (Y90 Microspheres) or Transcatheter Arterial Embolization (TACE) |
Estimated Enrollment: | 100 |
Study Start Date: | April 2008 |
Estimated Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |
OBJECTIVES:
Primary
OUTLINE: Patients complete FACT-Hep version 4 surveys on quality of life prior to initiation of embolization, and at 2 weeks and 1 month after completion of embolization.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, Illinois | |
Robert H. Lurie Comprehensive Cancer Center at Northwestern University | Recruiting |
Chicago, Illinois, United States, 60611-3013 | |
Contact: Clinical Trials Office - Robert H. Lurie Comprehensive Cancer 312-695-1301 cancer@northwestern.edu |
Principal Investigator: | Peggy Gilbertsen, RN, BS | Robert H. Lurie Cancer Center |
Study ID Numbers: | CDR0000593553, NU-07Q1, NU-IRB-STU00002799 |
Study First Received: | August 20, 2008 |
Last Updated: | February 6, 2009 |
ClinicalTrials.gov Identifier: | NCT00739167 History of Changes |
Health Authority: | Unspecified |
adult primary hepatocellular carcinoma advanced adult primary liver cancer liver metastases recurrent adult primary liver cancer |
Liver Diseases Digestive System Neoplasms Carcinoma, Hepatocellular Quality of Life Recurrence Carcinoma Liver Neoplasms |
Methamphetamine Digestive System Diseases Neoplasm Metastasis Gastrointestinal Neoplasms Amphetamine Hepatocellular Carcinoma |
Liver Neoplasms Neoplastic Processes Liver Diseases Neoplasms Pathologic Processes |
Digestive System Diseases Neoplasms by Site Digestive System Neoplasms Neoplasm Metastasis |